Submitted:
05 December 2024
Posted:
06 December 2024
You are already at the latest version
Abstract
Keywords:
| This Correlation report is simultaneously posted on several websites, including: https://correlation-canada.org/research/ https://denisrancourt.ca/ https://denisrancourt.substack.com/ https://archive.org/details/@dgr_legal_docs All Correlation reports are here: https://correlation-canada.org/research/ |
| Citation: Rancourt, DG. Medical Hypothesis: Respiratory epidemics and pandemics without viral transmission. CORRELATION Research in the Public Interest, Report, 02 December 2024. https://correlation-canada.org/respiratory-epidemics-without-viral-transmission/ |
Summary
| Table of Contents | |
| Summary | 1 |
| 1 Introduction | 3 |
| 2 An epidemiological phenomenon in need of explanation | 4 |
| 3 What are possible causes and what are causes that can be ruled out? | 4 |
| 3.1 Primary cause of death versus associated diseases or conditions | 5 |
| 3.2 Inferred respiratory medical conditions in the deaths contributing to Covid-period excess all-cause mortality | 5 |
| 3.3 Primary causes of death in excess all-cause mortality during the Covid period | 8 |
| 3.3.1 Ruled out: SARS-CoV-2 as a primary cause of death | 8 |
| 3.3.2 Hypothesis: Sudden and extraordinary stress from mandates and measures | 8 |
| 3.3.3 Hypothesis: Collectively amplified individual biological stress | 10 |
| 3.3.4 Hypothesis: Assaults from extraordinary medical interventions other than COVID-19 vaccination | 11 |
| 3.3.5 Hypothesis: Assaults by COVID-19 vaccination | 11 |
| 3.3.6 Hypothesis: Assaults from campaigns and measures associated in time and place with COVID-19 vaccine rollouts | 15 |
| 3.3.7 Discerning the COVID-19 vaccination and rollout-associated assault primary causes | 16 |
| 3.3.8 Hypothesis: Increased stressors cause surges in spontaneous microbial respiratory self-infection (aspiration pneumonia) | 16 |
| 3.3.9 Hypothesis: Spontaneous microbial respiratory self-infection (spontaneous pneumonia) without aspiration | 18 |
| 3.4 Is a pandemic of transmissionless bacterial pneumonia possible? | 18 |
| 3.5 Has a pandemic-causing viral respiratory pathogen ever existed? | 20 |
| 4 Conclusion | 21 |
| Acknowledgements | 22 |
| References | 22 |
1. Introduction
2. An epidemiological phenomenon in need of explanation
- A peak in excess all-cause mortality surges synchronously with the World Health Organization (WHO) 11 March 2020 declaration of a pandemic, in many national and sub-national jurisdictions (especially in the Northern Hemisphere).
- The said peak in excess all-cause mortality (nominally March-May 2020) does not occur in many (most) jurisdictions, including in the Northern Hemisphere.
- There are no similar peaks occurring prior to 11 March 2020, and there is essentially no detected excess all-cause mortality prior to approximately 11 March 2020 (in many years of data, in >100 countries).
- The magnitude of the said peak in excess all-cause mortality, normalized by jurisdictional population, is highly heterogeneous across jurisdictions in which it occurs, and it is often zero (i.e., undetected).
- There is contrary evidence of spatiotemporal spread of excess mortality in these peaks. All the said peaks occur essentially at the same time, irrespective of their differing magnitudes (normalized by jurisdictional population). The said peaks in excess all-cause mortality do not cross jurisdictional borders, do not grow into new geographic regions, and do not systematically have rising edges delayed in time as one moves away from the strongest centers of large-magnitude said peaks.
- High heterogeneity across jurisdictions of the magnitude of the said peak also occurs when the said peak is normalized by expected or historic baseline mortality under the peak (i.e., when it is expressed as a P-score), instead of by jurisdictional population. Since P-score excess mortality is measured in comparison to the intrinsic baseline mortality rate (by time period) in the jurisdiction, peaks expressed as P-scores include all the factors normally affecting mortality, such as age structure and prior health status. P-score mortality is thereby age and health-status adjusted.
- Normal mortality rates are generally exponential with age. Likewise, the mortality in the said peak is predominantly from the elderly population.
- The most intense said peaks, where they occur, occur in urban regions with high poverty and high population density. However, for example, the said peak is essentially absent from Eastern European countries.
- The excess all-cause mortality in the said peak, in well-documented cases, is quantitatively equal to or closely matched by the number of tabulated respiratory deaths, assigned as COVID-19 deaths, in the same time period, in the given jurisdiction.
3. What are possible causes and what are causes that can be ruled out?
- a primary cause of death, and
- an associated or proximal cause of death.
3.1. Primary cause of death versus associated diseases or conditions
“Some diseases have specific causes, the direct actions of certain particular, disease-producing agents, such as microbes, poisons, or physical injuries. Many more diseases are not caused by any one thing in particular; they result from the body’s own response to some unusual situation.”
- A poison leads to heart failure. Then the primary cause of death is the poison.
- A poison weakens the body’s defenses, leading to a massive intestinal infection and eventual respiratory and heart co-failures. Then the primary cause of death is the poison.
- Chronic biological stress causes exhaustion-phase collapse of the body’s resistance to the biological stress, and death follows (Selye, 1956). Then the primary cause of death is what caused the said chronic biological stress, which can be specific.
- Chronic psychological stress causes immunosuppression, enabling a severe respiratory infection from ambient microbes and air pollution, followed by death. Then the primary cause of death is what caused the said chronic psychological stress, which can be specific.
- A person is seriously ill for some reason, even dying. A medical intervention accelerates the death, and the person dies prematurely. Then the primary cause of death is the medical intervention.
- “we argue that social factors such as socioeconomic status and social support are likely ‘fundamental causes’ of disease that, because they embody access to important resources, affect multiple disease outcomes through multiple mechanisms, and consequently maintain an association with disease even when intervening mechanisms change.”
3.2. Inferred respiratory medical conditions in the deaths contributing to Covid-period excess all-cause mortality
“Finally, our examination of plausible mechanisms for the exceptionally large COVID-era mortality in the USA, given all our empirical observations, leads us to postulate that COVID-19 may largely be misdiagnosed bacterial pneumonia (using a faulty PCR test: Borger et al., 2021; and see Ginsburg and Klugman, 2020), that correctly assigned bacterial pneumonia itself largely goes untreated, while antibiotics (and Ivermectin) are withdrawn, in circumstances where large populations of vulnerable and susceptible residents have suppressed immune systems from chronic psychological stress induced by (“COVID response”) large-scale socio-economic disruption, and that the USA has, in the COVID-era, thus recreated the conditions that produced the horrendous bacterial pneumonia epidemic of 1918 (Morens et al., 2008) (Chien et al., 2009) (Sheng et al., 2011).”
- (Already outlined above: Intricate weekly temporal matching of the reported COVID-19 mortality and excess all-cause mortality for up to 3 years during the Covid period in the USA data.)
- Intricate weekly temporal matching of the reported COVID-19 mortality and excess all-cause mortality for the March-May 2020 peak (the said peak of Section 0) in Canada and Canadian provinces (Rancourt et al., in preparation).
- Respiratory infections are a major recognized cause of death for all ages, both historically and presently, which is consistent with the intrinsic vulnerability of the lungs and the unavoidable rate of constant breathing (and aspiration, see Section 0).
- The median ratio of excess all-cause mortality to reported COVID-19 mortality in the Covid period (2020-2022) for some 100 countries is 1.55 (Rancourt et al., 2024), which is not too different from 1.
- Many deaths occurred from early aggressive hospital treatments for respiratory conditions, such as mechanical ventilators, toxic experimental doses of drugs, and lethal palliative drug cocktails (March-May 2020 said peak of Section 0) (e.g., Bailey and Köhnlein, 2020; Chaillot, 2024, their Chapter 6; Menage, 2021; Rancourt, 2020, 2023a; Richardson et al., 2020; Roedl et al., 2021; Torjesen, 2021; Watts et al., 2021).
- The VAERS system of adverse effect reporting contains many post-vaccination nominally COVID-19 infections (e.g., Hickey and Rancourt, 2022, their Figures S3(a) and S4(a)).
- Post-vaccination nominally COVID-19 infections are common, and are generally more frequent and more serious following multiple COVID-19 vaccine doses (1st dose, 2nd dose, booster) (Amer et al., 2024, their Table 6).
3.3. Primary causes of death in excess all-cause mortality during the Covid period
3.3.1. Ruled out: SARS-CoV-2 as a primary cause of death
- It is incompatible with the large country-to-country heterogeneity of age and frailty adjusted (P-score) excess all-cause mortality rate (e.g., Rancourt et al., 2024, their sections 5.5 and 5.7; and see COVID-19 Forecasting Team, 2022, re heterogeneity of IFR).
- It is incompatible with the country-to-country spatiotemporal pattern of deaths, including the phenomenon of not crossing national borders. There is no evidence of spread, only local (by country) and time-specific assaults that do not geo-temporally evolve (e.g., Rancourt et al., 2024, their sections 4.11, 4.12 and 5.6).
- There was biological (including psychological) stress, induced by aggressive and life-changing mandates.
- There were deadly medical interventions (including denial of treatment) and overreaction directed by institutional messaging and propelled by managerial and professional self-interest.
- There was a coordinated international so-called response and global vaccination campaign with multiple rollouts, driven and protected by aggressive establishment and industry forces (Bergman, 2024; Homburg, 2024; Kennedy, 2021; Von, 2022).
- All-cause mortality is a record of the consequences.
3.3.2. Hypothesis: Sudden and extraordinary stress from mandates and measures
- The role of social dominance hierarchy, in both human and animal societies, as a structural and leading source of complex, situational and time-dependent stressors (dominance aggression) that primarily determine an individual’s (social-status-dependent) health and longevity.
- The dependence of biological adaptation to stress and failure (collapse) of biological adaption to stress on, not solely whether the biological stress is acute (episodic) or chronic (constant), and not solely on how the stress is experienced by the particular individual, but critically on the time sequence of the acting stressors of varying intensities; that is, on their time-type-intensity spectrum, which can have both regular and chaotic components.
“Therefore, it is not difficult to imagine that the massive socio-economic disruptions of the COVID-era would have caused undue chronic psychological stress and amplified dominance-hierarchy stress predominantly against those who are already at the bottom of the societal dominance hierarchy, and have the least means to adjust to dramatically new circumstances. The new circumstances include: loss of sources of income, both legitimate and illegal, increased social isolation, increased hierarchical impositions, constant fear propaganda, severe mobility restrictions, closing of public and corporate-public spaces previously used, enforcement and intimidation against private or informal gatherings, mobbing against those who do not cheerfully accept the ‘new reality’, and increased aggressions from equally stressed individuals. The missing means to adjust would include: undisturbed salary and ability to work from home, means to stay connected by Zoom (by video conferencing applications), large comfortable air-conditioned homes, means to home-school children in an adapted environment, nearby facilities for outside exercise, private facilities for physical exercise, undisturbed shopping by home delivery, undisturbed self-medication, continued access to health care, and so on.”
- Being connected to a mechanical ventilator or simply held at an ICU (intensive care unit) station are extreme immobilizations not unlike those imposed on the mice in the study of Li et al. (2023), but of longer duration on particularly fragile individuals.
- Contrary to caregiver expectations, medically ordered bedrest is virtually never beneficial to ill and recovering patients. In the words of Allen et al. (1999):
- “In 15 trials investigating bed rest as a primary treatment, no outcomes improved significantly and nine worsened significantly for some conditions (acute low back pain, labour, proteinuric hypertension during pregnancy, myocardial infarction, and acute infectious hepatitis).”
- Likewise, imposed low mobility and medically recommended bedrest is always harmful to elderly patients. In the words of Brown et al. (2004):
- “Conclusion: Low mobility and bedrest are common in hospitalized older patients and are important predictors of adverse outcomes. This study demonstrated that the adverse outcomes associated with low mobility and bedrest may be viewed as iatrogenic events leading to complications, such as functional decline.”
3.3.3. Hypothesis: Collectively amplified individual biological stress
3.3.4. Hypothesis: Assaults from extraordinary medical interventions other than COVID-19 vaccination
- coordinated denial of antibiotics or Ivermectin against bacterial pneumonia
- systematic use of mechanical ventilators and their associated medications
- experimental treatment protocols (large-dose hydroxychloroquine, HCQ)
- new palliative and psychological medication protocols, overdoses (e.g., midazolam) (Marliot et al., 2020; Sy, 2024)
- isolation of vulnerable individuals in medical or institutional facilities
- denial of intensive care and disease management facilities
- denial of home and community care medical services
- aggressive-testing accidents
- accidents and infections from reduced attending staff in care homes
- encouraged voluntary or involuntary assisted dying (Marliot et al., 2020; Menage, 2021; Sy, 2024)
- increased prevalence of medical errors due to declared-pandemic conditions
3.3.5. Hypothesis: Assaults by COVID-19 vaccination
-
30% of countries (37 of 124) have no detected excess all-cause mortality in all of 2020, only later when vaccines are rolled out
- 124 countries had sufficient all-cause mortality data (the data for Cabo Verde was too noisy) to determine whether excess all-cause mortality started after the end of 2020, after the vaccines were introduced.
- Of these 124 countries, 37 countries (30% of countries) had no detectable excess all-cause mortality in 2020. For at least the first nine months of the declared pandemic (declared on 11 March 2020) these 37 countries had virtually no measurable excess all-cause mortality: Antigua and Barbuda, Australia, Barbados, Bermuda, Brunei, Cuba, Faroe Islands, Finland, French Guiana, French Polynesia, Gibraltar, Greenland, Hong Kong, Iceland, Jamaica, Japan, Macao, Malaysia, Martinique, Mauritius, Monaco, Mongolia, Namibia, New Caledonia, New Zealand, Norway, Philippines, Réunion, Saint Kitts and Nevis, Saint Vincent and the Grenadines, Seychelles, Singapore, South Korea, Suriname, Taiwan, Thailand, and Uruguay.
- To this list of 37 countries (Rancourt et al., 2024), we can add India (Rancourt, 2022).
- All these 37 + 1 countries have first peaks or increases in excess all-cause mortality (if present) occurring only after vaccination is initiated, or later when the bulk of injections have been administered and additional (booster) doses are rolled out (Rancourt et al., 2024; Rancourt, 2022).
-
100% of countries (110 countries with sufficient vaccination data) show varied associations between vaccine rollouts and excess mortality
- 110 countries of the 125 countries in the Rancourt et al. (2024) study had sufficient data (both vaccination and mortality data, which is not too noisy) to allow determinations of temporal associations.
- There were significant associations between COVID-19 vaccine rollouts and peaks or increases in excess all-cause mortality in all 110 of these countries (100% of countries) having sufficient data (Rancourt et al., 2024, their Appendix B): Albania, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Barbados, Belgium, Belize, Bermuda, Bolivia, Bosnia, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czechia, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Faroe Islands, Finland, France, French Guiana, French Polynesia, Georgia, Germany, Gibraltar, Greece, Guadeloupe, Guatemala, Hong Kong, Hungary, Iceland, Iran, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Liechtenstein, Lithuania, Luxembourg, Macao, Malaysia, Maldives, Malta, Mauritius, Mexico, Moldova, Monaco, Mongolia, Montenegro, Namibia, Netherlands, New Caledonia, New Zealand, Nicaragua, North Macedonia, Norway, Oman, Palestine, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saint Kitts and Nevis, Saint Vincent and the Grenadines, Serbia, Seychelles, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Sweden, Switzerland, Taiwan, Tajikistan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, USA, Uruguay, and Uzbekistan.
-
97% of countries (113 of 116) show a late-2021 early-2022 peak in excess all-cause mortality temporally associated with booster rollouts
- There were 116 of the 125 countries in the Rancourt et al. (2024) study that had sufficient and sufficient-quality data to ascertain the presence of the “22-0 feature”, a prominent or statistically evident excess mortality peak that occurs within one month or so of 1 January 2022 (their section 4.5). Of these 116 countries, 113 countries had the 22-0 feature in their excess all-cause mortality data (their section 4.5). The other 3 countries did not measurably exhibit the 22-0 feature (Italy, Macao, Taiwan).
- Therefore, 113 of 116 countries (97% of countries) exhibit a peak in excess all-cause mortality within one month or so of 1 January 2022 (the 22-0 feature, Rancourt et al., 2024, their section 4.5) coincident with (immediately following) the time at which many booster doses were synchronously rolled out globally. The booster rollouts are recognized as peaks in overall (all doses) COVID-19 vaccine administration (e.g., Rancourt et al., 2023a).
- The 113 countries having discernable 22-0 features in excess all-cause mortality were (Rancourt et al., 2024, their Appendix B): Albania, Andorra, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Barbados, Belgium, Belize, Bermuda, Bolivia, Bosnia, Brazil, Brunei, Bulgaria, Cabo Verde, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czechia, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Faroe Islands, Finland, France, French Guiana, French Polynesia, Georgia, Germany, Greece, Guadeloupe, Guatemala, Hong Kong, Hungary, Iceland, Iran, Ireland, Israel, Jamaica, Japan, Jordan, Kazakhstan, Kosovo, Kuwait, Kyrgyzstan, Latvia, Lebanon, Liechtenstein, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Martinique, Mauritius, Mayotte, Mexico, Moldova, Monaco, Mongolia, Montenegro, Namibia, Netherlands, New Caledonia, New Zealand, Nicaragua, North Macedonia, Norway, Oman, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Réunion, Romania, Russia, Saint Kitts and Nevis, Saint Vincent and the Grenadines, San Marino, Serbia, Seychelles, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Sweden, Switzerland, Tajikistan, Thailand, Transnistria, Tunisia, Turkey, Ukraine, United Kingdom, USA, and Uruguay.
- Among these 113 countries having discernable 22-0 features in excess all-cause mortality, some of the most striking associations between a peak in vaccine rollout and the 20-2 feature occur for the 12 countries (Rancourt et al., 2024): Australia (and see: Rancourt et al., 2022a, 2023a, 2023b), Austria, Czechia, Hong Kong, Hungary, Poland, Qatar, Romania, Russia, Saint Vincent and the Grenadines, Slovakia, and Ukraine.
-
64% of countries (50 of 78) show a late-2022 early-2023 sharp peak in excess all-cause mortality temporally associated with booster rollouts
- There were 78 of the 125 countries in the Rancourt et al. (2024) study that had sufficient and sufficient-quality data to ascertain the presence of the “23-0 feature”, a prominent or statistically evident excess mortality peak that occurs within one month or so of 1 January 2023, less than 5 months prior to the declaration of 5 May 2023 of the end of the declared pandemic (their section 4.4).
- Of these 78 countries with sufficient data, 50 countries had the 23-0 feature (their section 4.4) in their excess all-cause mortality data. These 50 countries were (Rancourt et al., 2024, their Appendix B): Austria, Belgium, Canada, Chile, Croatia, Cyprus, Czechia, Denmark, Ecuador, Estonia, Finland, France, French Guiana, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Macao, Moldova, Netherlands, New Zealand, Norway, Paraguay, Poland, Portugal, Puerto Rico, Qatar, Russia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, United Kingdom, and USA.
- The other 28 of the 78 countries with sufficient data did not measurably exhibit the 23-0 feature (Rancourt et al., 2024, their section 4.4). These 28 countries were: Albania, Armenia, Azerbaijan, Bosnia, Colombia, Egypt, Faroe Islands, Georgia, Guadeloupe, Kazakhstan, Kosovo, Kyrgyzstan, Malaysia, Martinique, Mayotte, Mexico, Mongolia, Montenegro, North Macedonia, Oman, Philippines, Réunion, Serbia, Uruguay, Bulgaria, Mauritius, New Caledonia, and Romania.
- Therefore, 50 of 78 countries (64% of countries) exhibited a peak in excess all-cause mortality within one month or so of 1 January 2023 (the 23-0 feature, Rancourt et al., 2024, their section 4.4) coincident with (immediately following) the time at which many booster doses were synchronously rolled out globally, in the last booster rollout prior to the declaration of the end of the declared pandemic. The booster rollouts are recognized as peaks in overall (all doses) COVID-19 vaccine administration (Rancourt et al., 2024; e.g., Rancourt et al., 2023a).
- Although Bulgaria does not have the 23-0 feature (a distinct peak near 1 January 2023), it does have a broader and somewhat earlier peak structure in its excess all-cause mortality, which matches the vaccine rollout at that time (mid to end of 2022). Similar circumstances may be occurring in: Albania, Armenia, Colombia, Egypt, Georgia, Malaysia, North Macedonia, Philippines, Mauritius, and New Caledonia. (Rancourt et al., 2024, their Appendix B)
-
Particularly striking examples of vaccine-mortality associations in several specific countries
- Several countries showed striking examples of vaccine-mortality associations in which the vaccine rollout is synchronous with the only exceptionally large excess all-cause mortality feature (Rancourt et al., 2024, their Appendix B): Bahamas, Cuba, French Polynesia, Gibraltar, Jamaica, Japan, Malaysia, New Caledonia, and Suriname. Here, note that Cuba developed its own vaccine.
- Similarly striking examples include (Rancourt et al., 2024, their Appendix B): Guadeloupe, Hong Kong, Maldives, Mauritius, Namibia, Philippines, Qatar, and Tunisia.
- The injection causes death by direct toxicity. Cationic lipids are candidates for toxic components.
- The injection causes death by inducing an immune overreaction. The resulting immune assault, analogous to an allergic reaction, is enough to accelerate and cause the death.
- The injection and repeated injections (2nd dose and boosters) cause immunosuppression making the patient generally more susceptible to infections and less able to defend against existing infections, including respiratory infections, in turn causing death. (See Section 0 regarding Amer et al., 2024, their Table 6.)
- A frail patient is infected or additionally infected by a person who was made more infectious by injection-induced immunosuppression ― either another patient or a caregiver, for example. Their death is accelerated where it otherwise would not have been.
- As an accident of the physical injection itself, the vaccine product can be introduced directly into a large blood vessel, rather than into the muscle tissue as intended. The resulting bolus then potentially leads to fatal consequences by high-concentration rapid mass bulk delivery to sensitive organs, systems or tissues (Girardot, 2024).
3.3.6. Hypothesis: Assaults from campaigns and measures associated in time and place with COVID-19 vaccine rollouts
“…it is possible that the observed strong correlations occur due to one or several hidden factors, rather than from a direct causal relationship due to challenge via toxicity of the injected substance.
For example, we might postulate that the teams of attendants who walk into the various institutions housing frail people to administer the latest booster during the period of a rapid rollout, are accompanied by or serve the dual function of a team of attendants who test for positive cases of presumed COVID-19. Each positive test or diagnostic determination, in turn, whether real or false, could have significant negative health consequences for the individual, such as isolation, removal to a different location, confinement, and aggressive chemical and mechanical medical treatment.”
- the use of incorrectly stored or handled COVID-19 vaccination products
- incorrect combinations of COVID-19 vaccination products from different manufacturers
- incorrect physical administrations of the COVID-19 vaccine, using rushed or ill-trained staff
- testing for COVID-19, and the associated consequences of positive test results
- more aggressive or extreme immobilisation and isolation enforcement during the vaccine rollout
- the psychological stress of being coerced into re-vaccination, in the institutional environment
- administration of influenza or other vaccinations
- administration of medications intended to facilitate acceptance or to alleviate side effects of the injections
- disrupted patient care schedule, including regular medication, meals and hydration
- transmitted stress of the attendants, or infections from the attendants
- and so on
3.3.7. Discerning the COVID-19 vaccination and rollout-associated assault primary causes
“… To constrain whether or not vaccine toxicity directly causes measurable mortality, versus (for example) the fatal impact of other and concomitant large-scale public health interventions, … the researcher should have access to vaccine-status-discriminated all-cause mortality data. Such data will constrain more definitively whether the COVID-19 vaccination rollouts have life-saving benefits, or cause additional mortality, and the degree of these relations. This data is needed for the same countries in which strong temporal associations are present between rapid vaccine rollouts and sharp peaks in excess all-cause mortality.”
3.3.8. Hypothesis: Increased stressors cause surges in spontaneous microbial respiratory self-infection (aspiration pneumonia)
“Studies of the lung microbiome have challenged our assumptions of lung sterility and of bacterial access to the lungs through aspiration (microaspiration or macroaspiration) and inhalation. Specifically, genomic methods have defined a complex taxonomic landscape of bacteria in the lung and revealed the presence of diverse communities of microbiota.
-
A dominant risk factor for aspiration pneumonia is immunosuppression, whereas:
- biological and psychological stress suppress immune response (Section 0)
- including immobilization and isolation (Section 0)
-
Dominant known risk factors for aspiration pneumonia include several iatrogenic causes, which increased significantly with pandemic so-called response, including:
- diagnostic bias and general denial of antibiotic treatments (Mandell and Niederman, 2019; Rancourt et al., 2021a, their section 5)
- mechanical ventilation (Pneumatikos et al., 2009)
- sedatives, hypnotics, muscle relaxants, sleeping pills, psycho psychotics (Gupte et al., 2022; Teramoto, 2022; their Table 1)
- drugs that cause dry mouth (e.g., anticholinergic drugs, tricyclic antidepressants) (Teramoto, 2022; their Table 1)
- tube feeding (placing of the nasogastric tube itself disturbs swallowing function) (Teramoto, 2022; their Table 1)
- polypharmacy (unexpected side effects of agents) (Teramoto, 2022; their Table 1)
- endotracheal intubation tube, tracheotomy tubing (Teramoto, 2022; their Table 1)
- depressed consciousness, use of opioids, anesthesia (Asai and Isono, 2014)
- depressive disorder (Gupte et al., 2022)
- suicide attempt (Teramoto, 2022; their Table 1)
- medications for the treatment of gastroesophageal reflux (Gupte et al., 2022)
-
A dominant risk factor for aspiration pneumonia is suppression of the defenses against aspiration, whereas
- sedation significantly increases aspiration (Gupte et al., 2022)
- immobilization and being bedridden significantly increases aspiration (Prass et al., 2006)
- any obstruction to breathing (which presumably would include face mask wearing) significantly increases aspiration (“impair[ed] pulmonary clearance”, Gupte et al., 2022)
- medical or other suppression of coughing significantly increases aspiration and aspiration pneumonia (Ebihara and Ebihara, 2011)
- Comorbid conditions associated with death from aspiration pneumonia include alcoholism and opioid related disorders (Gupte et al., 2022). The use of alcohol and opioids may have increased in the elderly during the Covid period.
3.3.9. Hypothesis: Spontaneous microbial respiratory self-infection (spontaneous pneumonia) without aspiration
3.4. Is a pandemic of transmissionless bacterial pneumonia possible?
- A sudden assault on many countries using measures that increase the likelihood and/or lethality of aspiration pneumonia (0) or spontaneous pneumonia (0) among elderly and frail groups, and/or
- A sudden socio-economic collapse affecting many countries, of a type that increases the likelihood and/or lethality of aspiration pneumonia (0) or spontaneous pneumonia (0) among elderly and frail groups, and/or
- A sudden man-made or natural environmental change affecting many countries, of a type that increases the likelihood and/or lethality of aspiration pneumonia (0) or spontaneous pneumonia (0) among elderly and frail groups
- lower temperatures, known to cause significant biological stress (Section 0), with cold homes known to be associated with respiratory emergencies in winter (Rudge and Gilchrist, 2005)
- lower atmospheric humidity, known to cause dry mouth, in turn known to increase aspiration, also expected to affect respiratory tract tissues and the associated microbiome, known to increase aerosol load and residency time
- larger atmospheric pressure, and larger atmospheric pressure variability, expected to affect circulation, known to affect severity of pneumonia (during airplane flights)
- larger partial pressure of oxygen, unknown effect on pneumonia incidence, large potential to affect respiratory tract microbiome and immune response (Park et al., 1992)
- decreased daylight hours, unknown effect on pneumonia incidence, presumed connection to vitamin D (Chatfield et al., 2007)
- decreased geomagnetic activity, unknown effect on pneumonia incidence
- loss or change of care staff (including increased negligence)
- change in staff management (including loss of oversight)
- change in diet or its administration (including fluids)
- change in public-health safety protocols and conditions (including isolation)
- loss of access to facilities or services (including washrooms or attendants)
- change in administered medications
- increased immobilization (in-bed or in-room) for any reason
- change in environmental conditions (e.g., temporary loss of indoor heat)
- transferred or transmitted fear or stress from staff
- increased frequent physical displacements (e.g., for treatment or testing)
4. Conclusion
Acknowledgements
References
- Ader and Cohen (1993): Ader R, Cohen N. Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol. 1993;44:53-85. [CrossRef] [PubMed]
- Allen et al. (1999): Chris Allen, Paul Glasziou, Chris Del Mar /// Bed rest: a potentially harmful treatment needing more careful evaluation /// The Lancet, Volume 354, Issue 9186, 1999, Pages 1229-1233, ISSN 0140-6736. [CrossRef]
- Amer et al. (2024): Amer, S.A., Al-Zahrani, A., Imam, E.A. et al. /// Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study /// Sci Rep 14, 4785 (2024). [CrossRef]
- Asai and Isono (2014): Takashi Asai, Shiroh Isono /// Residual Neuromuscular Blockade after Anesthesia: A Possible Cause of Postoperative Aspiration-induced Pneumonia. /// Anesthesiology 2014; 120:260–262. [CrossRef]
- Bagcchi (2023): Sanjeet Bagcchi /// WHO's Global Tuberculosis Report 2022 /// www.thelancet.com/microbe Vol 4 January 2023, p. e20. [CrossRef]
- Bailey (2022): Mark Bailey /// A Farewell To Virology (Expert Edition) /// (15 September 2022) https://drsambailey.com/a-farewell-to-virology-expert-edition/ /// archived: https://archive.org/details/afarewell- to-virology-expert-edition/.
- Bailey and Köhnlein (2020): Sam Bailey, Claus Köhnlein /// PCR Pandemic: Interview with Dr Claus Köhnlein /// https://drsambailey.com/ (video interview, 35m45s duration), 27 October 2020 /// https://drsambailey.com/resources/videos/interviews/pcr-pandemic-interview-with-dr-claus-kohnlein/.
- Bailey et al. (2024): Sam Bailey et al. (HFDF Team) /// Exploding the Spanish Flu Myth /// HFDF Team internet resource, 20 June 2024 /// https://healthfreedomdefense.org/exploding-the-spanish-flu-myth/ (accessed 13 July 2024) /// Archived: https://archive.ph/qPB6L /// As a video, with show notes: https://drsambailey.com/resources/videos/viruses-unplugged/exploding-the-spanish-flu-myth/.
- Baussano et al. (2010): Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, et al. /// Tuberculosis Incidence in Prisons: A Systematic Review. /// PLoS Med, 2010, 7(12): e1000381. [CrossRef]
- Bergman (2024): Frank Bergman /// Dutch Government Official Admits Covid Pandemic Was ‘Military Operation’: ‘Ministry of Health Obeys NATO’ /// Slay News, 9 November 2024 /// https://slaynews.com/news/dutch-government-official-admits-covid-pandemic-military-operationministry- health-obeys-nato/ /// archived: https://web.archive.org/web/20240000000000*/https://slaynews.com/news/dutch-government-officialadmits- covid-pandemic-military-operation-ministry-health-obeys-nato/ /// archived: https://archive.ph/agFFj /// accessed 18 November 2024.
- Borger et al. (2021): Pieter Borger, Bobby Rajesh Malhotra, Michael Yeadon, Clare Craig, Kevin McKernan, Klaus Steger, Paul McSheehy, Lidiya Angelova, Fabio Franchino, Thomas Binder, Henrik Ullrich, Makoto Ohashi, Stefano Scoglio, Marjolein Doesburg-van Kleffens, Dorothea Gilbert, Rainer J. Klement, Ruth Schruefer, Berber W. Pieksma, Jan Bonte, Bruno H. Dalle Carbonare, Klaus Steger, and Ulrike Kämmerer /// Addendum to the Corman-Drosten Review Report. /// OSF Preprints. 12 January 2021.
- Braithwaite (1984): John Braithwaite /// Chapter 6: “The corporation as pusher” in: CORPORATE CRIME in the pharmaceutical industry /// Routledge Kegan Paul (London), 1984, 440 pages, ISBN 0-7102-0049-8 /// https://johnbraithwaite.com/wp-content/uploads/2016/06/Corporate-Crime-in-the-Pharmac.pdf. ISBN 0-7102-0049-8.
- Brandl et al. (2022): Hanja B. Brandl, Jens C. Pruessner, Damien R. Farine /// The social transmission of stress in animal collectives /// Proceedings of the Royal Society B: Biological Sciences, 2022, 289: 20212158 ///. [CrossRef]
- Brown et al. (2004): Brown, C.J., Friedkin, R.J. and Inouye, S.K. /// Prevalence and Outcomes of Low Mobility in Hospitalized Older Patients /// Journal of the American Geriatrics Society, 2004, 52: 1263-1270. [CrossRef]
- Byrd et al. (2018): Byrd, A., Belkaid, Y., Segre, J. /// The human skin microbiome. /// Nat Rev Microbiol 16, 143- 155 (2018). [CrossRef]
- CDC (2023): CDC /// COVID-19 Mortality Overview > Deaths by Select Demographic and Geographic Characteristics /// https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm (archived by CDC on 27 September 2023, accessed 19 June 2024) /// Also archived at: https://archive.ph/https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm.
- Chaillot (2024): Pierre Chaillot /// Covid 19: Decoding Official Data: Mortality, tests, vaccines, hospitals. The truth emerges /// Publisher: L'Artilleur (May 27 2024), Paperback: 422 pages /// ISBN-10: 2810012393, ISBN-13: 978-2810012398.
- Chapman and Dyerly (1964): John S. Chapman and Margaret D. Dyerly, and Don R. Powell (statistical assistance) /// Social and Other Factors in Intrafamilial Transmission of Tuberculosis /// American Review of Respiratory Disease, 1964, 90(1), pp. 48–60. /// https://www.atsjournals.org/doi/abs/10.1164/arrd.1964.90.1.48.
- Chatfield et al. (2007): Chatfield, S.M., Brand, C., Ebeling, P.R. and Russell, D.M. /// Vitamin D deficiency in general medical inpatients in summer and winter. /// Internal Medicine Journal, 2007, 37: 377-382. [CrossRef]
- Chien et al. (2009): Yu-Wen Chien, Keith P. Klugman, David M. Morens /// Bacterial pathogens and death during the 1918 influenza pandemic. /// N Engl J Med. 2009 Dec 24;361(26):2582-3. doi: 10.1056/NEJMc0908216. PMID: 20032332. [CrossRef]
- Cohen et al. (1991): Cohen S, Tyrrell DA, Smith AP /// Psychological Stress and Susceptibility to the Common Cold /// New England Journal of Medicine. Massachusetts Medical Society, 325(9), pp. 606–612. [CrossRef]
- Cohen et al. (1997a): Cohen, Sheldon; Line, Scott; Manuck, Stephen B.; Rabin, Bruce S.; Heise, Eugene R.; Kaplan, Jay R. /// Chronic Social Stress, Social Status, and Susceptibility to Upper Respiratory Infections in Nonhuman Primates /// Psychosomatic Medicine, May/June 1997 - Volume 59 - Issue 3 - p 213-221. [CrossRef]
- Cohen et al. (1997b): Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr. /// Social Ties and Susceptibility to the Common Cold /// JAMA, 277(24), pp. 1940–1944. [CrossRef]
- Cohen et al. (2007): Sheldon Cohen, Denise Janicki-Deverts, Gregory E Miller /// Psychological Stress and Disease /// JAMA, 298(14), pp. 1685–1687. [CrossRef]
- COVID-19 Forecasting Team (2022): Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. /// Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24. Erratum in: Lancet. 2022 Apr 16;399(10334):1468. PMID: 35219376; PMCID: PMC8871594. [CrossRef]
- Dattani et al. (2023): Saloni Dattani, Fiona Spooner, Hannah Ritchie and Max Roser (2023) /// Tuberculosis /// Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/tuberculosis [Online Resource] on 15 July 2024.
- de Haro-Licer et al. (2013): de Haro-Licer J, Roura-Moreno J, Vizitiu A, González-Fernández A, González-Ares JA. /// Long term serious olfactory loss in colds and/or flu. /// Acta Otorrinolaringol Esp. 2013 Sep- Oct;64(5):331-8. English, Spanish. doi: 10.1016/j.otorri.2013.04.003. Epub 2013 Aug 12. PMID: 23948436. [CrossRef]
- DeWitte and Wood (2008): DeWitte SN, Wood JW /// Selectivity of black death mortality with respect to preexisting health /// Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1436-41. doi: 10.1073/pnas.0705460105. Epub 2008 Jan 28. PMID: 18227518; PMCID: PMC2234162. [CrossRef]
- Dhabhar (2009): Firdaus S. Dhabhar /// Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology /// Neuroimmunomodulation 1 June 2009; 16 (5): 300–317. [CrossRef]
- Dhabhar (2014): FS Dhabhar /// Effects of stress on immune function: the good, the bad, and the beautiful /// Immunologic Research. 2014 May; 58(2-3): 193-210. doi: 10.1007/s12026-014-8517-0. PMID: 24798553. [CrossRef]
- Dharmadhikari et al. (2011): Ashwin S. Dharmadhikari, Randall J. Basaraba, Martie L. Van Der Walt, Karin Weyer, Matsie Mphahlele, Kobus Venter, Paul A. Jensen, Melvin W. First, Sydney Parsons, David N. McMurray, Ian M. Orme, Edward A. Nardell /// Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis /// Tuberculosis, Volume 91, Issue 4, 2011, Pages 329-338, ISSN 1472-9792. [CrossRef]
- Dietert et al. (2017): Dietert, Kristina et al. /// Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. /// PloS one vol. 12,11 e0188251. 20 Nov. 2017. [CrossRef]
- Dye et al. (1999): Dye C, Scheele S, >Dolin P, Pathania V, Raviglione MC, for the WHO Global Surveillance and Monitoring Project. /// Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country. /// JAMA. 1999;282(7):677–686. [CrossRef]
- Ebihara and Ebihara (2011): Satoru Ebihara, Takae Ebihara /// Cough in the elderly: A novel strategy for preventing aspiration pneumonia /// Pulmonary Pharmacology, Therapeutics, Volume 24, Issue 3, 2011, Pages 318-323, ISSN 1094-5539. [CrossRef]
- Fischer (1996): David Hackett Fischer /// The Great Wave: Price Revolutions and the Rhythm of History /// Oxford University Press, 1996, 536 pages, ISBN-13 978-0-19-512121-6 (Pbk.), ISBN 0-19-512121-X (Pbk.).
- Ginsburg and Klugman (2020): Ginsburg AS, Klugman KP. /// COVID-19 pneumonia and the appropriate use of antibiotics. /// Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11. PMID: 33188730; PMCID: PMC7833845. [CrossRef]
- Girardot (2024): Marc Girardot /// The Needle’s Secret: Unraveling the mystery of vaccine harm, and the bolus theory revolution /// (Independently published, 22 March 2024) /// paperback, 276 pages, ISBN-13: 979-8884699793.
- Gøtzsche (2013): Peter Gøtzsche /// Deadly Medicines and Organised Crime /// CRC Press: Taylor Francis Group, 2013, 310 pages, ISBN-13: 978-1-84619-884-7 (pbk).
- Gøtzsche (2012): Peter Gøtzsche /// Mammography Screening: Truth, Lies and Controversy /// London: Radcliffe Publishing, 2012. /// CRC Press; 1st edition (Jan. 21 2012), Paperback: 400 pages, ISBN-10: 1846195853. ISBN-13: 978-1846195853. /// Review response: Mammography screening: truth, lies, and controversy, Gøtzsche, Peter C, The Lancet, Volume 380, Issue 9838, 218, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61216-1/fulltext.
- Gøtzsche (2016): Peter C Gøtzsche /// Peter C Gøtzsche: Prescription drugs are the third leading cause of death /// thebmjopinion, 16 June 2016 /// https://blogs.bmj.com/bmj/2016/06/16/peter-c-gotzsche-prescriptiondrugs- are-the-third-leading-cause-of-death/.
- Gupte et al. (2022): Gupte, T., Knack, A. Cramer, J.D. /// Mortality from Aspiration Pneumonia: Incidence, Trends, and Risk Factors. /// Dysphagia 37, 1493–1500 (2022). [CrossRef]
- Hickey and Rancourt (2022): Hickey J, Rancourt DG /// “Nature of the toxicity of the COVID-19 vaccines in the USA”. ResearchGate [Preprint] (9 February 2022). Available at: http://dx.doi.org/10.13140/RG.2.2.14217.93289 | Correlation Republication, https://correlationcanada. org/VAERS-toxicity-of-COVID19-vaccines/. [CrossRef]
- Hickey et al. (in preparation): Early publication will be provided at Correlation: https://correlationcanada. org/research/.
- Homburg (2024): Stefan Homburg /// Whistleblow Uncovers Covid Scam /// video, YouTube Stefan Homburg channel, https://www.youtube.com/@StHomburg, 5 November 2024, Berlin /// https://www.youtube.com/watch?v=-j7qjedth3A /// Description: A whistleblower obtained 10GB from Robert-Koch-Institute, the German CDC. This so-called RKI-Leak reveals that Covid was a scam from start to finish. The presentation took place in the second largest room of the German Bundestag, which is actually intended for committees of inquiry. Recorded 2 November 2024 in Berlin, English subtitles provided by the speaker. Internet sources: The RKI-Leak - The Federal Ministry of Health has confirmed the authenticity of the leak. Download : https://rki-transparenzbericht.de/ Search tool: https://www.rkileak.com/ /// accessed on 16 November 2024 (51,702 views).
- Houben et al. (2022): Houben RMGJ, Esmail H, Cobelens F, Williams CML, Coussens AK. /// Tuberculosis prevalence: beyond the tip of the iceberg. /// Lancet Respir Med. 2022 Jun;10(6):537-539. doi: 10.1016/S2213- 2600(22)00184-9. PMID: 35659006. [CrossRef]
- Jacobs et al. (2015): Enno Jacobs, Ingrid Ehrhardt, Roger Dumke. /// New insights in the outbreak pattern of Mycoplasma pneumoniae. /// International Journal of Medical Microbiology, Volume 305, Issue 7, 2015, Pages 705-708, ISSN 1438-4221. [CrossRef]
- Johnson and Rancourt (2022): Johnson, J.A. and Rancourt, D.G. /// Evaluating the Effect of Lockdowns On All- Cause Mortality During the COVID Era: Lockdowns Did Not Save Lives /// ResearchGate [preprint] (9 July 2022) (16 pages), http://dx.doi.org/10.13140/RG.2.2.34191.46242 | And published by Brownstone Institute (6 September 2022): https://brownstone.org/articles/lockdowns-did-not-save-lives/. [CrossRef]
- Joshi et al. (2006): Joshi R, Reingold AL, Menzies D, Pai M /// Tuberculosis among health-care workers in low and middle-income countries: A systematic review. /// PLoS Med 2006, 3(12):e494. [CrossRef]
- Kayser-Jones et al. (1999): Kayser-Jones, J., Schell, E.S., Porter, C., Barbaccia, J.C. and Shaw, H. /// Factors Contributing to Dehydration in Nursing Homes: Inadequate Staffing and Lack of Professional Supervision. /// Journal of the American Geriatrics Society, 1999, 47: 1187-1194. [CrossRef]
- Kennedy (2021): Robert F. Kennedy Jr. /// Chapter 12 (Germ Games): War Games: Genesis of the Biosecurity State /// pages 378-445 (incl. 297 endnotes) in: The Real Anthony Fauci - Bill Gates, Big Pharma, and the Global War on Democracy and Public Health (RF Kennedy Jr., 2021, Skyhorse Publishing, Children’s Health Defence, ISBN: 978-1-5107-6680-8, pp. 449).
- Koivula et al. (1994): Koivula I, Sten M, Mäkelä PH. /// Risk factors for pneumonia in the elderly. /// Am J Med. 1994 Apr;96(4):313-20. doi: 10.1016/0002-9343(94)90060-4. PMID: 8166149. [CrossRef]
- Kuzmenko (2019): Kuzmenko, N.V. /// Seasonal Variations in Atmospheric Pressure, Partial Oxygen Density, and Geomagnetic Activity as Additional Synchronizers of Circannual Rhythms. /// BIOPHYSICS 64, 599–609 (2019). [CrossRef]
- Lewin (1951): Lewin, K. /// Field theory in social science: selected theoretical papers /// Edited by Dorwin Cartwright, Harpers (New York), 1951, 346 pages /// https://archive.org/details/dli.ernet.503983/.
- Li et al. (2023): Li, C.-C.; Munalisa, R.; Lee, H.-Y.; Lien, T.-S.; Chan, H.; Hung, S.-C.; Sun, D.-S.; Cheng, C.-F.; Chang, H.-H. /// Restraint Stress-Induced Immunosuppression Is Associated with Concurrent Macrophage Pyroptosis Cell Death in Mice /// Int. J. Mol. Sci. 2023, 24, 12877. [CrossRef]
- Link and Phelan (1995): Link, Bruce G., and Jo Phelan. /// Social Conditions As Fundamental Causes of Disease. /// Journal of Health and Social Behavior, 1995, 80–94. [CrossRef]
- Liu et al. (2023): Liu YN, Zhang YF, Xu Q, Qiu Y, Lu QB, Wang T, Zhang XA, Lin SH, Lv CL, Jiang BG, Li H, Li ZJ, Gao GF, Yang WZ, Hay SI, Wang LP, Fang LQ, Liu W; Chinese Center for Disease Control and Prevention Etiology Surveillance Study Team of Acute Respiratory Infections. /// Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. /// Lancet Microbe. 2023 May;4(5):e330-e339. doi: 10.1016/S2666-5247(23)00031- 9. Epub 2023 Mar 28. PMID: 37001538. [CrossRef]
- MMakary and Daniel (2016): Makary M A, Daniel M. /// Medical error—the third leading cause of death in the US /// BMJ 2016; 353 :i2139. [CrossRef]
- Mamelund (2006): Mamelund SE /// A socially neutral disease? Individual social class, household wealth and mortality from Spanish influenza in two socially contrasting parishes in Kristiania 1918-19 /// Soc Sci Med. 2006 Feb;62(4):923-40. doi: 10.1016/j.socscimed.2005.06.051. Epub 2005 Aug 8. PMID: 16084634. [CrossRef]
- Mamelund et al. (2021): Mamelund S-E, Shelley-Egan C, Rogeberg O /// The association between socioeconomic status and pandemic influenza: Systematic review and meta-analysis /// PLoS ONE 16(9): e0244346. [CrossRef]
- Mandell and Niederman (2019): Mandell LA, Niederman MS. /// Aspiration Pneumonia. (Review) /// N Engl J Med. 2019 Feb 14;380(7):651-663. doi: 10.1056/NEJMra1714562. PMID: 30763196. [CrossRef]
- Marik (2001): Marik PE. /// Aspiration pneumonitis and aspiration pneumonia. (Review) /// N Engl J Med. 2001 Mar 1;344(9):665-71. doi: 10.1056/NEJM200103013440908. PMID: 11228282. [CrossRef]
- Marik and Kaplan (2003): Marik PE, Kaplan D. /// Aspiration pneumonia and dysphagia in the elderly. /// Chest. 2003 Jul;124(1):328-36. doi: 10.1378/chest.124.1.328. PMID: 12853541. [CrossRef]
- Marliot et al. (2020): Marliot G, Penel N, Gamblin V. /// Switch in use of midazolam for cancer patients during the COVID-19 pandemic. /// J Oncol Pharm Pract. 2020 Oct;26(7):1817-1818. doi: 10.1177/1078155220948929. Epub 2020 Aug 14. PMID: 32791947. [CrossRef]
- Martin and Martin-Granel (2006): Martin PM, Martin-Granel E. /// 2,500-year evolution of the term epidemic. /// Emerg Infect Dis. 2006 Jun;12(6):976-80. doi: 10.3201/eid1206.051263. PMID: 16707055; PMCID: PMC3373038. [CrossRef]
- Martora et al. (2023): Martora F, Battista T, Ruggiero A, Scalvenzi M, Villani A, Megna M, Potestio L. /// The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature. /// Viruses. 2023 Jun 23; 15(7): 1423. doi: 10.3390/v15071423. PMID: 37515110; PMCID: PMC10384785. [CrossRef]
- Menage (2021): Janet Menage /// Rapid Response: Assisted dying is open to Abuse /// BMJ Response, 14 September 2021 /// https://www.bmj.com/content/374/bmj.n2128/rr-11 /// All Rapid Responses to the same article are here: https://www.bmj.com/content/374/bmj.n2128/rapid-responses.
- Morey et al. (2015): Morey JN, Boggero IA, Scott AB, Segerstrom SC /// Current Directions in Stress and Human Immune Function /// Curr Opin Psychol. 2015 Oct 1;5:13-17. doi: 10.1016/j.copsyc.2015.03.007. PMID: 26086030; PMCID: PMC4465119. [CrossRef]
- Morens et al. (2008): Morens DM, Taubenberger JK, Fauci AS. /// Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. /// The Journal of infectious diseases, vol. 198,7 (2008): 962-70. [CrossRef]
- Norgan and Pritt (2018): Norgan AP, Pritt BS. /// Parasitic Infections of the Skin and Subcutaneous Tissues. /// Adv Anat Pathol. 2018 Mar;25(2):106-123. doi: 10.1097/PAP.0000000000000183. PMID: 29351090. [CrossRef]
- O’Garra et al. (2013): O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. /// The immune response in tuberculosis. /// Annu Rev Immunol. 2013;31:475-527. doi: 10.1146/annurev-immunol-032712- 095939. PMID: 23516984. [CrossRef]
- Palmer et al. (2023): Palmer et al. / Doctors for COVID Ethics /// mRNA Vaccine Toxicity /// D4CE.org, version 2.1 (October 27, 2023) (235 pages). https://d4ce.org/mRNA-vaccine-toxicity/.
- Panagioti et al. (2019): Panagioti M, Khan K, Keers R N, Abuzour A, Phipps D, Kontopantelis E et al. /// Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis /// BMJ 2019; 366 :l4185. [CrossRef]
- Paquette et al. (2024): Maude Paquette, Matthew Magyar, Christian Renaud. /// Mycoplasma pneumoniae /// CMAJ 2024 October 1; 196:E1120. [CrossRef]
- Park et al. (1992): Matthew K. Park, Roy A. M. Myers, Louis Marzella /// Oxygen Tensions and Infections: Modulation of Microbial Growth, Activity of Antimicrobial Agents, and Immunologic Responses /// Clinical Infectious Diseases, Volume 14, Issue 3, March 1992, Pages 720–740. [CrossRef]
- Pellegrino et al. (2016): Pellegrino R, Walliczek-Dworschak U, Winter G, Hull D, Hummel T. /// Investigation of chemosensitivity during and after an acute cold. /// Int Forum Allergy Rhinol. 2017; 7: 185–191. [CrossRef]
- Peters et al. (2021): Eva M.J. Peters, Manfred Schedlowski, Carsten Watzl, Ulrike Gimsa /// To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2 /// Neurobiology of Stress, Volume 14, 100296. ISSN 2352-2895. [CrossRef]
- Plumlee et al. (2021): /// Courtney R. Plumlee, Fergal J. Duffy, Benjamin H. Gern, Jared L. Delahaye, Sara B. Cohen, Caleb R. Stoltzfus, Tige R. Rustad, Scott G. Hansen, Michael K. Axthelm, Louis J. Picker, John D. Aitchison, David R. Sherman, Vitaly V. Ganusov, Michael Y. Gerner, Daniel E. Zak, Kevin B. Urdahl /// Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis /// Cell Host Microbe, Volume 29, Issue 1, 68 - 82.e5. [CrossRef]
- Pneumatikos et al. (2009): Ioannis A. Pneumatikos, Christos K. Dragoumanis, Demosthenes E. Bouros, David S. Warner, Mark A. Warner /// Ventilator-associated Pneumonia or Endotracheal Tube-associated Pneumonia?: An Approach to the Pathogenesis and Preventive Strategies Emphasizing the Importance of Endotracheal Tube. /// Anesthesiology 2009; 110:673–680. [CrossRef]
- Prass et al. (2006): Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. /// Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. /// Stroke. 2006 Oct;37(10):2607-12. [CrossRef]
- Prenderville et al. (2015): /// Adding fuel to the fire: the impact of stress on the ageing brain /// Trends in Neurosciences, 38(1), pp. 13–25. [CrossRef]
- Rancourt (2020): Rancourt, D.G. /// All-cause mortality during COVID-19 — No plague and a likely signature of mass homicide by government response /// ResearchGate, 2 June 2020. http://dx.doi.org/10.13140/RG.2.2.24350.77125 | Available at: https://archive.org/details/boe-expertwitness- denis-rancourt-nci-ce-nc - pp. 774-799. [CrossRef]
- Rancourt (2021): Rancourt, DG /// Do Face Masks Reduce COVID-19 Spread in Bangladesh? Are the Abaluck et al. Results Reliable? /// denisrancourt.ca (20 September 2021) /// https://denisrancourt.ca/entries.php?id=106 - archived: https://archive.ph/yHbWO - republished: https://www.globalresearch.ca/do-face-masksreduce- covid-19-spread-bangladesh-abaluck-et-al-results-reliable/5756323?pdf=5756323.
- Rancourt (2022): Rancourt, DG /// Probable causal association between India’s extraordinary April-July 2021 excess-mortality event and the vaccine rollout /// Correlation Research in the Public Interest, 5 December 2022 /// https://correlation-canada.org/report-probable-causal-association-between-indias-extraordinary-apriljuly- 2021-excess-mortality-event-and-the-vaccine-rollout/.
- Rancourt (2023a): Rancourt, Denis /// Dr. Denis Rancourt Unveiling All-Cause Mortality: A Critical Analysis of the Pandemic Declaration and Vaccination Rollout ― Testimony of Denis Rancourt to the National Citizens Inquiry (Canada), Ottawa, 17 May 2023, https://rumble.com/v2ohtte-physicist-dr-denis-rancourt-presentshis- findings-on-all-cause-mortality-ot.html /// Denis Rancourt Virtual Testimony follow up to the National Citizens Inquiry (Canada), 28 June 2023, https://rumble.com/v2wpyqu-national-citizens-inquiry-denisrancourt- virtual-testimony.html /// NCI website: https://nationalcitizensinquiry.ca/.
- Rancourt (2023b): Rancourt DG. /// Realities of Health (Fundamental nature of health) /// Invited special session talk at: International Crisis Summit IV (ICS4), 17 November 2023 (18 minutes), Bucharest, Romania. /// https://denisrancourt.ca/videos.php?id=111 /// https://denisrancourt.substack.com/p/fundamental-natureof- health /// https://rumble.com/v3x6q0o-denis-rancourt-realities-of-health-very-interesting.html.
- Rancourt (2024): Rancourt, DG /// My response to Tracy Beth Hoeg’s criticisms of our “17M vaccine deaths” calculation /// https://denisrancourt.ca/entries.php?id=136 (24 January 2024) /// https://web.archive.org/web/20240126173523/https://denisrancourt.ca/uploads_entries/1706187792521_Re ply%20to%20Fact%20Checker%20Hoeg%20on%2017M%20paper----5.pdf.
- Rancourt et al. (2020): Rancourt, D.G., Baudin, M. and Mercier, J. (2020) /// Evaluation of the virulence of SARSCoV- 2 in France, from all-cause mortality 1946-2020 /// ResearchGate, 20 August 2020 [Preprint]. [CrossRef]
- Rancourt et al. (2021a): Rancourt, D.G., Baudin, M. and Mercier, J. /// Nature of the COVID-era public health disaster in the USA, from all-cause mortality and socio-geo-economic and climatic data. /// Research Gate (25 Ocbtober 2021). [CrossRef]
- Rancourt et al. (2021b): Rancourt, D.G., Baudin, M. and Mercier, J. /// Analysis of all-cause mortality by week in Canada 2010-2021, by province, age and sex: There was no COVID-19 pandemic, and there is strong evidence of response-caused deaths in the most elderly and in young males. /// Research Gate (6 August 2021. [CrossRef]
- Rancourt et al. (2022a): Rancourt, D.G., Baudin, M. and Mercier, J. /// Probable causal association between Australia’s new regime of high all-cause mortality and its COVID-19 vaccine rollout. /// Correlation Research in the Public Interest, 20 December 2022 /// https://correlation-canada.org/report-probable-causalassociation- between-australias-new-regime-of-high-all-cause-mortality-and-its-covid-19-vaccine-rollout/.
- Rancourt et al. (2022b): Rancourt, D.G., Baudin, M. and Mercier, J. /// COVID-Period Mass Vaccination Campaign and Public Health Disaster in the USA: From age/state-resolved all-cause mortality by time, age-resolved vaccine delivery by time, and socio-geo-economic data /// Research Gate (2 August 2022) /// http://dx.doi.org/10.13140/RG.2.2.12688.28164 /// Also available at: https://vixra.org/abs/2208.0023 and archived here https://archive.ph/lFNwK. [CrossRef]
- Rancourt et al. (2022c): Rancourt, D.G., Baudin, M. and Mercier, J. /// Proof that Canada’s COVID-19 mortality statistics are incorrect. /// Correlation Research in the Public Interest, 5 October 2022 /// https://correlationcanada. org/report-proof-that-canadas-covid-19-mortality-statistics-are-incorrect/.
- Rancourt et al. (2023a): Rancourt, D.G., Baudin, M., Hickey, J., Mercier, J. /// COVID-19 vaccine-associated mortality in the Southern Hemisphere /// CORRELATION Research in the Public Interest, Report, 17 September 2023. https://correlation-canada.org/covid-19-vaccine-associated-mortality-in-the-Southern- Hemisphere/.
- Rancourt et al. (2023b): Rancourt, D.G., Baudin, M., Hickey, J. and Mercier, J. /// Age-stratified COVID-19 vaccine-dose fatality rate for Israel and Australia /// Correlation Research in the Public Interest, 9 February 2023 /// https://correlation-canada.org/report-age-stratified-covid-19-vaccine-dose-fatality-rate-for-israeland- australia/.
- Rancourt and Hickey (2023): Rancourt DG and Hickey J /// Quantitative evaluation of whether the Nobel-Prizewinning COVID-19 vaccine actually saved millions of lives /// CORRELATION Research in the Public Interest, Brief Report, 08 October 2023 (115 pages). https://correlation-canada.org/nobel-vaccine-and-all-causemortality/ .
- Rancourt et al. (2024): Rancourt DG, Hickey J, Linard C. /// Spatiotemporal variation of excess all-cause mortality in the world (125 countries) during the Covid period 2020-2023 regarding socio economic factors and public-health and medical interventions. /// CORRELATION Research in the Public Interest, Report, 19 July 2024 (521 pages). https://correlation-canada.org/covid-excess-mortality-125-countries.
- Rancourt et al. (in preparation): Early publication will be provided at Correlation: https://correlation-canada.org/research/.
- Richardson et al. (2020): Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., … Davidson, K. W. /// Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. /// JAMA. [CrossRef]
- Riley et al. (1959): Riley R. L., Mills C. C., Nyka W., Weinstock N., Storey P. B., Sultan L. U., Riley M. C., Wells W. F. /// Aerial Dissemination of Pulmonary Tuberculosis. A Two-Year Study of Contagion in a Tuberculosis Ward. /// 19602701598, English, Journal article, 0096-5294, 70, (2), American Journal of Hygiene (185–96) (1959). [CrossRef]
- Rodrigues (2009): Rodrigues, S. M., LeDoux, J. E., & Sapolsky, R. M. /// The Influence of Stress Hormones on Fear Circuitry. /// Annual Review of Neuroscience, 2009, 32(1), 289–313. [CrossRef]
- Roedl et al. (2021): Roedl K, Jarczak D, Thasler L, Bachmann M, Schulte F, Bein B, Weber CF, Schäfer U, Veit C, Hauber HP, Kopp S, Sydow K, de Weerth A, Bota M, Schreiber R, Detsch O, Rogmann JP, Frings D, Sensen B, Burdelski C, Boenisch O, Nierhaus A, de Heer G, Kluge S. /// Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. /// Aust Crit Care. 2021 Mar;34(2):167-175. [CrossRef]
- Rudge and Gilchrist (2005): Rudge J, Gilchrist R. /// Excess winter morbidity among older people at risk of cold homes: a population-based study in a London borough. /// J Public Health (Oxf). 2005 Dec;27(4):353-8. doi: 10.1093/pubmed/fdi051. Epub 2005 Sep 9. PMID: 16155051. [CrossRef]
- Salminen (2022): Salminen, A. /// Clinical perspectives on the age-related increase of immunosuppressive activity /// J Mol Med 100, 697–712 (2022). [CrossRef]
- Sapolsky (2005): Robert M Sapolsky /// The Influence of Social Hierarchy on Primate Health (Review) /// Science, 29 April 2005, vol. 308, pages 648-652. [CrossRef]
- Selye (1936): SELYE, H. /// A Syndrome produced by Diverse Nocuous Agents /// Nature 138, 32 (1936). [CrossRef]
- Selye (1956): Hans Selye /// The Stress of Life /// McGraw-Hill Publ., ©1956, 1976, 1984 /// Paperback, revised edition, 1978, ISBN 0-07-056212-1, pp. 515.
- Selye (1976a): Hans Selye //// Stress in Health and Disease /// 1st Edition - , 1976, (encyclopedic other and systematic review) pp. 1302 /// eother ISBN: 9781483192215 /// https://www.sciencedirect.
- Selye (1976b): Selye H. /// Forty years of stress research: principal remaining problems and misconceptions /// Can Med Assoc J. 1976 Jul 3;115(1):53-6. PMID: 1277062; PMCID: PMC1878603. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1878603/.
- Seneff et al. (2022): Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. /// Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs /// Food Chem Toxicol. 2022 Jun;164:113008. doi: 10.1016/j.fct.2022.113008. Epub 2022 Apr 15. PMID: 35436552; PMCID: PMC9012513. [CrossRef]
- Sheng et al. (2011): Z. Sheng, D.S. Chertow, X. Ambroggio, S. McCall, R.M. Przygodzki, R.E. Cunningham, O.A. Maximova, J.C. Kash, D.M. Morens, J.K. Taubenberger /// Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. /// Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16416-21. doi: 10.1073/pnas.1111179108. Epub 2011 Sep 19. PMID: 21930918; PMCID: PMC3182717. [CrossRef]
- Silk (2002): Silk, J.B. /// Practice random acts of aggression and senseless acts of intimidation: The logic of status contests in social groups /// Evol. Anthropol., 2002, 11: 221-225. [CrossRef]
- Sy (2024): Wilson Sy /// Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic /// Medical Clinical Research (ISSN: 2577 - 8005), 2024, vol. 9(2), pp. 1-21. [CrossRef]
- Sydenham (1676): Thomas Sydenham /// Medical Observations (book title translated from the Latin by Greenwood) /// see Greenwood (1919): M. Greenwood / Sydenham as an Epidemiologist / Proc R Soc Med. 1919;12(Sect Epidemiol State Med):55-76. PMID: 19980701; PMCID: PMC2066736. / https://pmc.ncbi.nlm.nih.gov/articles/PMC2066736/.
- Szabo et al. (2017): Szabo S, Yoshida M, Filakovszky J, Juhasz G. /// "Stress" is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration /// Curr Pharm Des. 2017;23(27):4029-4041. [CrossRef]
- Teramoto (2022): Shinji Teramoto /// The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia (Review) /// Respiratory Investigation, Volume 60, Issue 1, 2022, Pages 45-55, ISSN 2212-5345. [CrossRef]
- Torjesen (2021): Torjesen I. /// Covid-19: When to start invasive ventilation is “the million dollar question” /// BMJ 2021; 372 :n121. [CrossRef]
- Torres et al. (2021): Torres, A., Cilloniz, C., Niederman, M.S. et al. /// Pneumonia. /// Nat Rev Dis Primers 7, 25 (2021). [CrossRef]
- Turner et al. (2017): Turner RD, Chiu C, Churchyard GJ, Esmail H, Lewinsohn DM, Gandhi NR, Fennelly KP. /// Tuberculosis Infectiousness and Host Susceptibility. /// J Infect Dis. 2017 Nov 3;216(suppl_6):S636-S643. doi: 10.1093/infdis/jix361. PMID: 29112746; PMCID: PMC5853924. [CrossRef]
- Volkert et al. (2019): Dorothee Volkert, Anne Marie Beck, Tommy Cederholm, Alfonso Cruz-Jentoft, Sabine Goisser, Lee Hooper, Eva Kiesswetter, Marcello Maggio, Agathe Raynaud-Simon, Cornel C. Sieber, Lubos Sobotka, Dieneke van Asselt, Rainer Wirth, Stephan C. Bischoff /// ESPEN guideline on clinical nutrition and hydration in geriatrics /// Clinical Nutrition, Volume 38, Issue 1, 2019, Pages 10-47, ISSN 0261-5614. [CrossRef]
- Von (2022): Theo Von /// Robert F. Kennedy Jr. Informs Us About A Simulated Pandemic Response Event /// video, YouTube Theo Von Clips channel, https://www.youtube.com/@TheoVonClips, 9 May 2022, #TheoVonClips /// https://www.youtube.com/watch?v=AnKlKiLhdew /// Description: Excerpt from Robert F. Kennedy Jr. | TPW 370 /// accessed on 17 November 2024 (10,715 views).
- Watts et al. (2021): WATTS A, POLYCHRONOPOULOU E, PUEBLA NEIRA D. /// TRENDS IN MECHANICAL VENTILATION AND MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19: A RETROSPECTIVE ANALYSIS. /// Chest. 2021 Oct;160(4):A1127. doi: 10.1016/j.chest.2021.07.1033. Epub 2021 Oct 11. PMCID: PMC8503238. [CrossRef]
- Zuercher et al. (2019): Zuercher, P., Moret, C.S., Dziewas, R. et al. /// Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. /// Crit Care 23, 103 (2019). [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
